Watch this interactive webcast of a live CCO webinar tailored to the multidisciplinary oncology team to gain expert perspectives on the care of patients with lymphomas during the COVID-19 pandemic.
Early prospective data show a low rate of seroconversion in patients with CLL who received COVID-19 mRNA vaccines. How can we improve vaccine protection against COVID-19 in this vulnerable patient population?
Download this “living” slideset updated after ASH 2021 to gain an expert’s perspective on managing lymphomas during the COVID-19 pandemic, including key data on COVID-19 outcomes in this population, seroconversion after infection and vaccination, and implications of SARS-CoV-2 infection on cancer treatment.
Download this “living” slideset updated after ASH 2021 for an expert’s perspective on multidisciplinary care of patients with lymphomas during the COVID-19 pandemic, including strategies for addressing vaccine hesitancy, minimizing infection risk, and managing “long-haul” COVID-19.
In this downloadable PDF resource, multidisciplinary experts answer healthcare professionals’ questions on COVID-19 vaccination and prophylaxis, modifying cancer treatment, and managing adverse events in patients with lymphomas during the COVID-19 pandemic.